NCT00046826View on ClinicalTrials.gov

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2001

Primary Completion Date

June 30, 2007

Study Completion Date

October 31, 2009

Conditions
Prostate Cancer
Interventions
DRUG

docetaxel

DRUG

estramustine phosphate sodium

DRUG

thalidomide

Trial Locations (2)

06856

Whittingham Cancer Center at Norwalk Hospital, Norwalk

06904

Carl and Dorothy Bennett Cancer Center at Stamford Hospital, Stamford

Sponsors

Lead Sponsor

Nuvance Health
All Listed Sponsors
lead

Nuvance Health

OTHER